Omeprazole
important information for the patient.
This medicine should always be taken exactly as described in the patient leaflet or as directed by your doctor or pharmacist.
Helicid Control contains the active substance omeprazole, which belongs to a group of medicines called “proton pump inhibitors”. These medicines reduce the amount of acid produced in the stomach.
Helicid Control is used in adults for the short-term treatment of symptoms of gastroesophageal reflux disease (e.g., heartburn and acid regurgitation).
Gastroesophageal reflux disease is a condition in which acid from the stomach flows back into the esophagus (the tube that connects the throat to the stomach), causing inflammation and pain. This can cause symptoms such as a burning sensation in the chest rising to the throat (heartburn) and a sour taste in the mouth (acid regurgitation). To achieve symptom relief, it may be necessary to take the tablets for 2-3 consecutive days.
You should not take Helicid Control if any of the above applies to you. If you are in doubt, consult your doctor or pharmacist before taking Helicid Control.
Before starting to take Helicid Control, you should discuss this with your doctor or pharmacist.
You should not take Helicid Control for more than 14 days without consulting your doctor. If you do not feel better or your symptoms worsen, you should consult your doctor.
Helicid Control has been associated with serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP). If you notice any of the following symptoms, you should stop taking Helicid Control and seek medical help immediately.
While taking omeprazole, kidney inflammation may occur. Symptoms may include decreased urine output or blood in the urine and/or allergic reactions such as fever, rash, and joint pain. You should inform your doctor if you experience any of these symptoms.
Helicid Control may mask the symptoms of other serious diseases. Therefore, if you experience any of the following before or while taking Helicid Control, you should contact your doctor immediately:
Before taking the medicine, you should inform your doctor about a planned specific blood test (chromogranin A levels).
If you experience a skin rash, especially in areas exposed to sunlight, you should inform your doctor as soon as possible, as it may be necessary to stop taking Helicid Control. You should also inform your doctor about any other side effects, such as joint pain.
Patient should not take omeprazole as a preventive measure.
If you have taken Helicid Control for more than the maximum recommended duration of 14 days, you should read the following information.
If you have taken Helicid Control for more than three months, it is possible that the level of magnesium in your blood may be low. Low magnesium levels can cause tiredness, muscle cramps, confusion, seizures, dizziness, and a rapid heartbeat. If you experience any of these symptoms, you should inform your doctor immediately. Low magnesium levels can lead to low levels of potassium or calcium in the blood. Your doctor may recommend regular blood tests to monitor your magnesium levels.
You should tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
This is important because Helicid Control may affect the way some medicines work, and some medicines may affect the way Helicid Control works.
You should not take Helicid Control if you are taking a medicine containing nelfinavir(used to treat HIV infection).
You should tell your doctor or pharmacist if you are taking clopidogrel (used to prevent blood clots).
You should inform your doctor or pharmacist if you are taking any of the following medicines:
Helicid Control capsules can be taken with or without food.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, you should ask your doctor or pharmacist for advice before taking this medicine.
Omeprazole passes into breast milk, but it is unlikely to affect the baby when used in therapeutic doses. Your doctor will decide whether you can take Helicid Control while breastfeeding.
Studies do not show that omeprazole affects fertility.
Helicid Control does not affect the ability to drive or use machines. However, side effects such as dizziness and blurred vision (see section 4) may occur. If affected, you should not drive or operate machinery.
If you have been told by your doctor that you have an intolerance to some sugars, you should contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per capsule, which is essentially sodium-free.
This medicine should always be taken exactly as described in the patient leaflet or as directed by your doctor or pharmacist. If you are in doubt, you should ask your doctor or pharmacist.
The usual dose for adults is two 10 mg capsules once daily for 14 days. If symptoms do not improve after this time, you should contact your doctor.
To achieve symptom relief, it may be necessary to take the medicine for 2-3 consecutive days.
If you have difficulty swallowing the capsules:
If you take more Helicid Control than prescribed by your doctor, you should contact your doctor or pharmacist immediately.
Missed dose should be taken as soon as you remember. However, if it is time for your next dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Other side effects include:
In very rare cases, Helicid Control may affect the number of white blood cells in your blood, leading to a lack of immunity. If you experience an infection with symptoms such as fever with a severe deterioration in general health or fever with local signs of infection, such as sore throat, mouth, or urinary problems, you should see your doctor as soon as possible so that a lack of white blood cells (agranulocytosis) can be ruled out by a blood test. It is important that you inform your doctor that you are taking Helicid Control.
If you experience any side effects, including those not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder or its representative in Poland.
Reporting side effects will help to gather more information on the safety of this medicine.
Medicines should be kept out of the sight and reach of children.
Store in a dry place, at a temperature below 25°C. Protect from light.
The product is sensitive to moisture, so a desiccant is included in the cap. The cap should be tightened immediately after the product is removed from the packaging.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance is omeprazole in the form of omeprazole sodium, equivalent to 10 mg omeprazole.
The other ingredients are: sucrose spheres, lactose anhydrous, hypromellose, hydroxypropylcellulose, sodium lauryl sulfate, disodium phosphate dodecahydrate, macrogol 6000, talc, methacrylic acid-ethyl acrylate copolymer (1:1). Shell composition: iron oxide black, iron oxide red, titanium dioxide, iron oxide yellow, gelatin.
Hard gelatin capsule with an orange cap and light brown body, containing white to light yellowish-brown microgranules.
Bottle made of orange glass with a plastic cap and a desiccant, placed in a cardboard box.
Bottle made of HDPE with a polypropylene cap with a protective ring, containing silica gel as a desiccant, placed in a cardboard box.
Pack size: 14 or 28 gastro-resistant hard capsules.
Blister pack (OPA/Aluminum/HDPE + PE + desiccant + HDPE/Aluminum) placed in a cardboard box.
Blister pack (OPA/Aluminum/PVC/Aluminum) placed in a cardboard box.
Pack size: 14 or 28 gastro-resistant hard capsules.
Zentiva k.s., U kabelovny 130, Dolní Měcholupy, 102 37 Prague 10, Czech Republic
S.C. Zentiva S.A., 50 Theodor Pallady Blvd., District 3, Bucharest, code 032266, Romania
To obtain more detailed information, you should contact the local representative of the marketing authorization holder:
Zentiva Polska Sp. z o.o.
Bonifraterska 17
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.